CytoMed Therapeutics Limited Ordinary Shares (GDTC)
Stock · NASDAQ · Health Care
$0.88as of 10/16/2026
Price chart
Active signals
GDTC Signal Track Record
How signals performed across all stocks →What GDTC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 21 | -11.1% | 33% | July 24, 2026 |
| Bollinger Band Breakdown | 14 | -0.7% | 43% | July 23, 2026 |
| Bollinger Band Breakout | 12 | -8.9% | 25% | October 5, 2026 |
| 200-Day Moving Average TouchActive now | 7 | -2.1% | 14% | October 17, 2025 |
| Any 20-session window (baseline) | -3.3% | 38% |
Computed by MarketWall from daily closing prices since January 30, 2024. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About GDTC
CytoMed Therapeutics Limited, a clinical stage biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. The company's lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comp…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 42
- Website
- w2.cytomed.sg
Fundamentals
- 1-day range
- $0.82$0.87
- Market cap
- $9.50M
- P/E (trailing)
- —
- P/E (forward)
- -5.80
- EPS (trailing)
- $-0.30
- Dividend yield
- —
- Beta
- 0.03
- Avg. volume
- 78.5K
Forecasts
1 analyst ratings
CytoMed Therapeutics Limited Ordinary Shares Competitors
Chosen by industry and closest market cap.
- GDTCCytoMed Therapeutics Limited Ordinary Shares$0.88▲ 1.15%Market cap $9.50MP/E —$0.6801$3.68
- LSTALisata Therapeutics Inc. Common Stock$1.03▼ 3.74%Market cap $9.74MP/E —$0.98$5.07
- QNRXQuoin Pharmaceuticals Ltd. American Depositary Shares$3.9▼ 3.23%Market cap $9.18MP/E —$3.25$23.5
- ASBPAspire Biopharma Holdings Inc. Common Stock$8.78▲ 1.62%Market cap $9.14MP/E —$3.31$562.8
- IMRNImmuron Limited American Depositary Shares$0.982▼ 4.66%Market cap $8.88MP/E —$0.026$0.098
- LEXXLexaria Bioscience Corp. Common Stock$2.86▼ 4.35%Market cap $8.82MP/E —$2.43$21.6
- BIVIBioVie Inc. Class A Common Stock$1.2▲ 6.19%Market cap $10.18MP/E —$0.82$3.79
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GDTC CytoMed Therapeutics Limited Ordinary Shares | $9.50M | — | $0.88 | ▲ 1.15% | $0.6801$3.68 |
| LSTA Lisata Therapeutics Inc. Common Stock | $9.74M | — | $1.03 | ▼ 3.74% | $0.98$5.07 |
| QNRX Quoin Pharmaceuticals Ltd. American Depositary Shares | $9.18M | — | $3.9 | ▼ 3.23% | $3.25$23.5 |
| ASBP Aspire Biopharma Holdings Inc. Common Stock | $9.14M | — | $8.78 | ▲ 1.62% | $3.31$562.8 |
| IMRN Immuron Limited American Depositary Shares | $8.88M | — | $0.982 | ▼ 4.66% | $0.026$0.098 |
| LEXX Lexaria Bioscience Corp. Common Stock | $8.82M | — | $2.86 | ▼ 4.35% | $2.43$21.6 |
| BIVI BioVie Inc. Class A Common Stock | $10.18M | — | $1.2 | ▲ 6.19% | $0.82$3.79 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyYahoo · 10/9/2026
- CytoMed Therapeutics Receives Nasdaq Noncompliance NoticeBenzinga · 10/9/2026
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 9/29/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 9/21/2026
Insider Activity
Insider Actions →- Choo Chee Kong · July 20, 2026 · Buy100.0K @ $1.5
- Choo Chee Kong · July 14, 2026 · Buy100.0K @ $1.5
- Choo Chee Kong · May 13, 2026 · Buy112.0K @ $1.15
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
CytoMed Shares Included in After-Hours Movers List
CytoMed Therapeutics was listed among healthcare stocks moving in Tuesday's after-market session. The company trades within a wide 52-week range of $0.68 to $3.68, with current technical indicators showing an RSI of 45.8. This inclusion highlights recent price activity relative to its support level at $1.00.
CytoMed Shares Included in After-Hours Movers List. CytoMed Therapeutics was listed among healthcare stocks moving in Tuesday's after-market session. The company trades within a wide 52-week range of $0.68 to $3.68, with current technical indicators showing an RSI of 45.8. This inclusion highlights recent price activity relative to its support level at $1.00.